Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study

Francis J. Major, John A. Blessing, Steven G. Silverberg et al. · Cancer · 1993 · 665 citations · Full text

Medicine, Gynecology, Oncology +14

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus☆

Aaron H. Wolfson, M. Brady, Thomas F. Rocereto et al. · Gynecologic Oncology · 2007 · 258 citations · Full text

Medicine, Oncology, Radiation Oncology +8

Malignant mixed müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome

Michael Callister, Lois M. Ramondetta, Anuja Jhingran et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 209 citations

Medicine, Gynecology, Oncology +14

Phase II Evaluation of Paclitaxel and Carboplatin in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Matthew A. Powell, Virginia L. Filiaci, Peter G. Rose et al. · Journal of Clinical Oncology · 2010 · 171 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis

Deepika Nemani, Nandita Mitra, Mengye Guo et al. · Gynecologic Oncology · 2008 · 159 citations

Medicine, Oncology, Surgery +16